{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:14:31Z","timestamp":1740136471196,"version":"3.37.3"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p\/>\n               <jats:sec>\n                  <jats:title>OBJECTIVES<\/jats:title>\n                  <jats:p>Evidence of an association between postoperative survival and the presenting syndrome following coronary artery bypass grafting (CABG) is limited. Our goal was to evaluate whether the presenting symptoms of acute coronary syndrome (ACS) or stable ischaemic heart disease were associated with mid-term survival in patients undergoing CABG.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We performed a single-centre retrospective study involving consecutive CABG operations from 2011 to 2016. Post-discharge survival was ascertained via patient-level data linkage with the State of Connecticut vital statistics. Baseline and postoperative variables were compared between the two groups. The multivariate Cox proportional hazard model, adjusted for demographics and comorbidity, was used to show whether the presenting syndrome category was independently associated with mid-term survival.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>A total of 1631 patients were included: 794 with stable ischaemic heart disease and 837 with ACS. Patients with ACS who underwent CABG showed more comorbidities. The overall 30-day mortality rate was 1.8% (ACS 2.3% vs stable ischaemic heart disease 1.3%; P\u2009=\u20090.12). In-hospital, postoperative outcomes revealed higher rates of prolonged ventilation (11.7% vs 4.8%; P\u2009&amp;lt;\u20090.001), pneumonia (6.6% vs 3.9%; P\u2009=\u20090.016) and stay in the intensive care unit (3.7\u2009\u00b1\u20094.0 vs 3.2\u2009\u00b1\u20092.7\u2009days; P\u2009=\u20090.014) in patients with ACS. The overall mean duration of the long-term follow-up period was 27.9\u2009\u00b1\u200916.5\u2009months, during which 117 deaths occurred. The multivariable Cox proportional hazard model adjusted for demographics and comorbidity showed that ACS was not a predictor of mid-term mortality [hazard ratio (HR) 1.26, 95% confidence interval (CI) 0.84\u20131.90; P\u2009=\u20090.26]. Other significant predictors were cardiogenic shock (HR 2.12, 95% CI 1.04\u20134.33; P\u2009=\u20090.039) and history of congestive heart failure (HR 1.78, 95% CI 1.18\u20132.69; P\u2009=\u20090.0062).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>The presenting syndrome was not an independent predictor of the mid-term mortality rate. The results indicate that the classification of the presenting syndrome may be fluid and that clinical decision-making for postoperative care of patients who have CABG directed by category of presenting syndrome needs careful consideration. These data should be interpreted in the context of the limitations of this study.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/icvts\/ivz259","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T04:13:00Z","timestamp":1570507980000},"page":"243-248","source":"Crossref","is-referenced-by-count":1,"title":["Clinical significance of presenting syndromes on outcome after coronary artery bypass grafting"],"prefix":"10.1093","volume":"30","author":[{"given":"Syed Usman","family":"Bin Mahmood","sequence":"first","affiliation":[{"name":"Department of Surgery, Section of Cardiac Surgery, Yale University School of Medicine, New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Surgery, Section of Cardiac Surgery, Yale University School of Medicine, New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0046-752X","authenticated-orcid":false,"given":"Sameh","family":"Yousef","sequence":"additional","affiliation":[{"name":"Department of Surgery, Section of Cardiac Surgery, Yale University School of Medicine, New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2774-251X","authenticated-orcid":false,"given":"Clancy W","family":"Mullan","sequence":"additional","affiliation":[{"name":"Department of Surgery, Section of Cardiac Surgery, Yale University School of Medicine, New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abeel A","family":"Mangi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Section of Cardiac Surgery, Yale University School of Medicine, New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnar","family":"Geirsson","sequence":"additional","affiliation":[{"name":"Department of Surgery, Section of Cardiac Surgery, Yale University School of Medicine, New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"key":"2020012406563846700_ivz259-B1","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart Disease and Stroke Statistics\u20142018 update: a report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"2020012406563846700_ivz259-B2","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC Guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2020012406563846700_ivz259-B3","doi-asserted-by":"crossref","first-page":"g3859.","DOI":"10.1136\/bmj.g3859","article-title":"Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis","volume":"348","author":"Windecker","year":"2014","journal-title":"BMJ"},{"key":"2020012406563846700_ivz259-B4","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1161\/CIRCULATIONAHA.113.008227","article-title":"Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial","volume":"130(11 Suppl 1)","author":"Une","year":"2014","journal-title":"Circulation"},{"key":"2020012406563846700_ivz259-B5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jocs.12074","article-title":"Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis","volume":"28","author":"Deo","year":"2013","journal-title":"J Card Surg"},{"key":"2020012406563846700_ivz259-B6","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"2020012406563846700_ivz259-B7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/eurheartj\/ehy562","article-title":"Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial","volume":"39","author":"Stone","year":"2018","journal-title":"Eur Heart J"},{"key":"2020012406563846700_ivz259-B8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"2020012406563846700_ivz259-B9","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.athoracsur.2009.05.053","article-title":"The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1\u2013coronary artery bypass grafting surgery","volume":"88(1 Suppl)","author":"Shahian","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"2020012406563846700_ivz259-B10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4244\/EIJY15M10_07","article-title":"Outcome after percutaneous coronary intervention for different indications: long-term results from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)","volume":"12","author":"Fokkema","year":"2016","journal-title":"EuroIntervention"},{"key":"2020012406563846700_ivz259-B11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.amjcard.2009.03.052","article-title":"Comparison of long-term mortality after percutaneous coronary intervention in patients treated for acute ST-elevation myocardial infarction versus those with unstable and stable angina pectoris","volume":"104","author":"Hirsch","year":"2009","journal-title":"Am J Cardiol"},{"key":"2020012406563846700_ivz259-B12","first-page":"e362","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"127","author":"O'Gara","year":"2013","journal-title":"Circulation"},{"key":"2020012406563846700_ivz259-B13","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.athoracsur.2009.03.067","article-title":"Changing volumes, risk profiles, and outcomes of coronary artery bypass grafting and percutaneous coronary interventions","volume":"87","author":"Aldea","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"2020012406563846700_ivz259-B14","first-page":"e574","article-title":"2011 ACCF\/AHA\/SCAI Guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation"},{"key":"2020012406563846700_ivz259-B15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/CIRCRESAHA.116.308952","article-title":"Prognostic determinants of coronary atherosclerosis in stable ischemic heart disease: anatomy, physiology, or morphology?","volume":"119","author":"Ahmadi","year":"2016","journal-title":"Circ Res"},{"key":"2020012406563846700_ivz259-B16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/CIRCINTERVENTIONS.111.963934","article-title":"Composition of target lesions by near-infrared spectroscopy in patients with acute coronary syndrome versus stable angina","volume":"5","author":"Madder","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"2020012406563846700_ivz259-B17","first-page":"14","article-title":"[Comparison of characteristics of atherosclerotic plaques in patients with acute coronary syndrome and stable ischemic heart disease: data of multispiral computed tomography]","volume":"53","author":"Veselova","year":"2013","journal-title":"Kardiologiia"},{"key":"2020012406563846700_ivz259-B18","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jacc.2013.05.033","article-title":"Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89, 883 patients enrolled in randomized clinical trials and observational studies","volume":"62","author":"Garcia","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2020012406563846700_ivz259-B19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4244\/EIJV11I2A31","article-title":"Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention","volume":"11","author":"Vranckx","year":"2015","journal-title":"EuroIntervention"},{"key":"2020012406563846700_ivz259-B20","doi-asserted-by":"crossref","first-page":"628","DOI":"10.21037\/acs.2018.08.01","article-title":"Dual antiplatelet therapy versus aspirin monotherapy in diabetics with stable ischemic heart disease undergoing coronary artery bypass grafting","volume":"7","author":"Mori","year":"2018","journal-title":"Ann Cardiothorac Surg"},{"key":"2020012406563846700_ivz259-B21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jacc.2016.10.043","article-title":"Dual antiplatelet therapy versus aspirin monotherapy in diabetics with multivessel disease undergoing CABG: FREEDOM insights","volume":"69","author":"van Diepen","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2020012406563846700_ivz259-B22","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jtcvs.2016.04.047","article-title":"American College of Cardiology\/American Heart Association 2016 dual antiplatelet therapy (DAPT) focused update: implications for surgeons","volume":"152","author":"Shemin","year":"2016","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Interactive CardioVascular and Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/icvts\/article-pdf\/30\/2\/243\/31955195\/ivz259.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/icvts\/article-pdf\/30\/2\/243\/31955195\/ivz259.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T06:56:50Z","timestamp":1579849010000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/icvts\/article\/30\/2\/243\/5622897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,11,12]]},"published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/icvts\/ivz259","relation":{},"ISSN":["1569-9285"],"issn-type":[{"type":"electronic","value":"1569-9285"}],"subject":[],"published-other":{"date-parts":[[2020,2]]},"published":{"date-parts":[[2019,11,12]]}}}